MENU
+Compare
PMN
Stock ticker: NASDAQ
AS OF
Dec 20 closing price
Price
$0.92
Change
+$0.02 (+2.22%)
Capitalization
30.07M

PMN ProMIS Neurosciences Forecast, Technical & Fundamental Analysis

Industry Biotechnology
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PMN with price predictions
Dec 20, 2024

Momentum Indicator for PMN turns negative, indicating new downward trend

PMN saw its Momentum Indicator move below the 0 level on December 18, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 111 similar instances where the indicator turned negative. In of the 111 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PMN turned negative on December 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PMN entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PMN advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .

PMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PMN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.136) is normal, around the industry mean (14.529). P/E Ratio (23.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). PMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PMN is expected to report earnings to fall 151.61% to -15 cents per share on March 14

ProMIS Neurosciences PMN Stock Earnings Reports
Q4'24
Est.
$-0.16
Q3'24
Beat
by $0.38
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.14
The last earnings report on November 14 showed earnings per share of 31 cents, beating the estimate of -7 cents. With 45.64K shares outstanding, the current market capitalization sits at 30.07M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DFS173.163.89
+2.30%
Discover Financial Services
EIG50.810.27
+0.53%
Employers Holdings
SOHO1.02N/A
N/A
Sotherly Hotels
AOMR9.19-0.01
-0.11%
Angel Oak Mortgage REIT
HAE75.44-1.46
-1.90%
Haemonetics Corp

PMN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
+1.88%
SYRE - PMN
44%
Loosely correlated
+3.16%
BBIO - PMN
42%
Loosely correlated
+1.07%
ABOS - PMN
33%
Poorly correlated
+2.78%
LIXT - PMN
27%
Poorly correlated
+3.66%
ARGX - PMN
25%
Poorly correlated
-0.35%
More